Delivra Health Brands (DHB) Price & Analysis

Compare

99 Followers

DHB Stock Chart & Stats

C$0.18

C$0.00(0.00%)

At close: Jan 08 4:00 PM EST

C$0.18

C$0.00(0.00%)

Day’s Range― - ―

52-Week RangeC$0.11 - C$0.37

Previous CloseN/A

Volume20.60K

Average Volume (3M)26.13K

Market Cap

C$5.78M

Enterprise ValueC$5.03M

Total Cash (Recent Filing)C$3.25M

Total Debt (Recent Filing)C$2.19M

Price to Earnings (P/E)―

Beta1.60

Next Earnings

Mar 03, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding31,261,782

10 Day Avg. Volume58,945

30 Day Avg. Volume26,134

Financial Highlights & Ratios

PEG Ratio0.02

Price to Book (P/B)1.30

Price to Sales (P/S)0.41

P/FCF Ratio-7.30

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue GrowthSustained TTM revenue growth of ~32.9% indicates expanding product adoption and distribution reach in retail and e‑commerce channels. Durable top‑line expansion supports operating leverage and provides runway to absorb fixed costs, aiding a path to consistent profitability if maintained.

Gross MarginNear‑50% gross margins point to favorable product economics and pricing power in topical analgesics and personal care. High gross margin provides structural capacity to fund R&D, marketing, and SG&A while preserving upside to margins as scale improves and input costs are managed over months.

Manageable LeverageA debt-to-equity around 0.5 and positive equity deliver balance-sheet flexibility versus highly leveraged peers. Manageable leverage reduces near-term refinancing risk, supports disciplined capital allocation, and allows the company to pursue growth or bridge short cash deficits without immediate distress.

Bears Say

Negative Cash FlowConsistent negative operating and free cash flow (~-$0.68M TTM) weakens the firm's ability to self‑fund operations and reinvest. Over a multi‑month horizon this elevates funding and execution risk, increasing the likelihood of external financing needs that can dilute shareholders or constrain strategic moves.

Inconsistent ProfitabilitySwinging between headline profitability and losses signals execution volatility: slim EBITDA margins (~2.8%) and a negative net margin (~-6%) imply limited buffer for cost shocks. Structural improvement is required in operations or SG&A to ensure stable, predictable earnings over coming quarters.

Shrinking Assets & Weak ROEA declining asset base combined with a deeply negative TTM ROE (~-18.9%) signals capital inefficiency and reduced financial flexibility. If asset contraction continues, capacity to scale, invest in growth initiatives, or secure favorable financing will be impaired over the medium term.

Delivra Health Brands News

Delivra Health Brands Adds Veteran CPG Executive John Barrett to Board

Delivra Health Brands ( ($TSE:DHB) ) has shared an update. Delivra Health Brands has appointed John Barrett, a...

24d ago

Delivra Health Brands Reports Q1 2026 Growth in Dream Water® and LivRelief™

Delivra Health Brands ( ($TSE:DHB) ) has issued an update. Delivra Health Brands reported financial results for the...

4M ago

Delivra Health Brands Sees Revenue Growth Amid Strategic Shifts

An announcement from Delivra Health Brands ( ($TSE:DHB) ) is now available. Delivra Health Brands reported an 8%...

5M ago

Delivra Health Brands to Announce Annual Financial Results

Delivra Health Brands ( ($TSE:DHB) ) has shared an announcement. Delivra Health Brands Inc. announced it will release...

5M ago

Delivra Health Expands Global Reach with GCC Market Launch

An announcement from Delivra Health Brands ( ($TSE:DHB) ) is now available. Delivra Health Brands Inc. is expanding...

7M ago

Delivra Health Expands U.S. Reach Through QVC Partnership

Delivra Health Brands ( ($TSE:DHB) ) just unveiled an update. Delivra Health Brands has expanded its U.S. presence...

9M ago

Delivra Health Brands Enhances Investor Relations with New Partnerships

Delivra Health Brands ( ($TSE:DHB) ) has provided an update. Delivra Health Brands Inc. has engaged Global One...

9M ago

Delivra Health Achieves Positive Q3 EBITDA Amid Strategic Marketing Push

Delivra Health Brands ( ($TSE:DHB) ) has provided an announcement. Delivra Health Brands reported a positive adjusted EBITDA...

9M ago

Delivra Health Expands Dream Water® Brand with New Product Launch in Middle East

Delivra Health Brands ( ($TSE:DHB) ) has shared an update. Delivra Health Brands Inc. is expanding its Dream...

10M ago

Delivra Health Expands Dream Water® Line with New Sleep Gummies in Canada

The latest announcement is out from Delivra Health Brands ( ($TSE:DHB) ). Delivra Health Brands has announced the...

12M ago

DHB FAQ

What was Delivra Health Brands’s price range in the past 12 months?

Delivra Health Brands lowest stock price was C$0.11 and its highest was C$0.37 in the past 12 months.

What is Delivra Health Brands’s market cap?

Delivra Health Brands’s market cap is C$5.78M.

When is Delivra Health Brands’s upcoming earnings report date?

Delivra Health Brands’s upcoming earnings report date is Mar 03, 2026 which is in 8 days.

How were Delivra Health Brands’s earnings last quarter?

Currently, no data Available

Is Delivra Health Brands overvalued?

According to Wall Street analysts Delivra Health Brands’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Delivra Health Brands pay dividends?

Delivra Health Brands does not currently pay dividends.

What is Delivra Health Brands’s EPS estimate?

Delivra Health Brands’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Delivra Health Brands have?

Delivra Health Brands has 31,261,782 shares outstanding.

What happened to Delivra Health Brands’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Delivra Health Brands?

Currently, no hedge funds are holding shares in TSE:DHB

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Delivra Health Brands

Delivra Health Brands Inc. through its subsidiaries, provides lifestyle and wellness products to consumers and patients in regulated markets worldwide. The company is involved in selling of cannabis, liquid sleep shots, sleep powder packets, gummies, and pain relief creams. It offers its products under LivRelief, Dream Water, and LivRelief infused brand names. The company was formerly known as Harvest One Cannabis Inc. Delivra Health Brands Inc. is headquartered in Vancouver, Canada.